huh! good one, not sure if you are being serious. the

New Post Public Reply Private Reply Replies (1) Message Board
PowerPuncher

huh! good one, not sure if you are being serious. the market is big enough, the contacts are there, the product is working better than ever according to dealers and insiders (from what I have heard through investors whom i trust and know a hell of a lot more than i) so it theoretically is doable. if one researches the players involved you can see the contacts, experience, and know they only got involved because they smartly see a very big play at hand. otherwise, you have to ask yourself, why would they risk their money, career, business contacts, etc if they didn't think this was one of those rare once-in-a-lifetime shot (for most people anyway). so, the experience is there, the business acumen, the contacts, the work is there (building the foundation of the company and taking the right steps- EPA/Carb, testing and more testing and more testing and analysis plus partnerships with Velociti and LaunchIT...Delta...) and lets not forget Dongfeng. DF alone could be a multi-million dollar business, add the Wildcat, EPA approval, Carb cert and THE KEY: some big name, big time dealers-- which i am told they have,...) and all the ingredients are there.

The only thing remaining is continued growth, progress, military/gov't contracts and a lowering of the share structure plus uplisting. the market, sector, and business exists if the product can gain EPA/Carb and Big-name fleets who will announce tot he world the what, why's and how it is working out. the ceo has already said he's uplisting and intends to buyback shares.

I know someone who spoke with CEO about share reduction early on. remember HLNT had 10Bill shares at one point and the CEO reduced the share structure significantly on two separate occasions if i am not mistaken. but, anyway, when asked about a further ss reduction ceo said he has the ability to do so- and would when the time was right. i don't know if that still holds true as the details are not ones i am inclined to share here.

anyway, the last component i think is really not much of an issue according to what i believe, have read and come to know- legal issue is not as relevant even though it is my very strong opinion that this two year battle ends in favor of HLNT.

So, is the 2-3yr timeline reasonable for $2-$3 pps. Ask yourself what the market cap would be. then ask if you would buy the company for that amnt or if you think someone else would. currently with 2.6B shares with an untouched share structure the company would have to be worth $5.2B to $7.8B which is far from where the stock is now. They probably need to do about $200-$300million in revenues before the billion dollar discussions can be readily tangible and feel real, maybe breaking $100million in revenues gets you into the billion-dollar discussion club. With the current HY-Impact product line I figure that means HLNT is about 135,000 new units away.

Assume each unit returns HLNT about 2k on the corporate level with the new $7k-$8k pricing (if true). Remember 1/2 goes to AHS and margins (original spectacular on these models) is now less due to all the new folks that gotta get paid: LaunchIt, Velociti, Delta,...10,000 or so units this year, 25,000 or so units the next and the big jump to 100,000 units in 2014 probably gets you to the discussion. IN between HLNT gets audited, is fully reporting, and uplists where it will attract a much better funded group of savvy investors (and the legal issue is behind them). Now, there are too many unknown variables to get carried away with my math/projections/speculation but that is entirely doable to see $2-$3 if everything I have written comes to pass as is. Maybe sooner. Word is they have some big kahuna's in the bag.

Can't wait to find out though

SPO Networks, Inc. (SPOI) Stock Research Links

SPOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 115

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Paratus Energy Lands Petrobras Tender, Ties Finalizing

Updated Category News Views 25

Seagems Joint Venture Snags Petrobras Contract Let’s dive headfirst into this business update, because this one's got teeth, folks. Petrobras, the big dog in Brazil’s oil arena, has given the green light to Seagems’ bid, a joint venture half-owned by Paratus Energy Services Ltd. The target? A hefty pipe-laying support vessel (PLSV) contract starting in 2028. But...

Continue Reading
PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 13

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
Tuya Gears Up for Q3 Financial Results Amid AI Growth

Updated Category News Views 11

Tuya's Third Quarter: What Are We Watching? Alright, folks, Tuya's about to drop their third quarter financial results like it's a hot potato. Circle November 23, 2026, on your calendars. That's when we'll get the goods on whether this AI cloud heavyweight is coasting or crushing it. Conference Call: The Gathering of Numbers The number-crunching brigade kickstarts at 7:30...

Continue Reading
Nevada Organic Phosphate Plans Share Consolidation

Updated Category News Views 24

The Drill Down on Nevada Organic Phosphate's Strategic Moves There's a lot to unpack here as Nevada Organic Phosphate Inc. (CSE: NOP) rolls out its big game plan. They're looking to consolidate shares, flex their financial muscles, and maybe spray some high-octane fuel on their market positioning. Could be a smart move if they pull it off, but that's a big 'if' hanging in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 386

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 584

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 35

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 133

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding America's Growing Net Debtor Status: Implications Ahead

Updated Category News Views 181

Shifting Dynamics of America's Net Debtor Status By Jamie McGeever Foreign investment in the U.S. has consistently outnumbered American investments abroad for several decades. This persistent imbalance has raised concerns among analysts about potential repercussions for the dollar's confidence. Despite these warnings, the anticipated crisis regarding this dynamic has not...

Continue Reading
Understanding Doximity's Short Interest Trends and Insights

Updated Category News Views 115

Diving Deeper into Doximity's Short Interest Analysis Doximity (DOCS) has attracted attention in recent financial discussions due to its short interest metrics. Recently, it was reported that the short percent of float for Doximity has decreased by 4.22%. This decline translates to approximately 5.64 million shares sold short, constituting about 4.54% of the company’s...

Continue Reading
Explore the Future of Biologics at Apogee's R&D Day

Updated Category News Views 100

Join Apogee Therapeutics' First Virtual R&D Day Apogee Therapeutics, Inc., a promising clinical-stage biotechnology firm, is poised to present its inaugural virtual Research and Development Day. Scheduled for 10:00 a.m. ET on a soon-to-come date, this event invites those interested in the transformative work happening in the field of biotechnology. Unveiling Innovations...

Continue Reading
Empowering Education: Oklahoma City School Choice Showcase

Updated Category News Views 122

Oklahoma City School Choice Showcase Set to Inspire Families Students from around Oklahoma City are gearing up for a fantastic event at Dove Science Academy, with a heartfelt message highlighting their love for their schools. The exciting gathering will showcase K–12 school choice options available in the state, aligning perfectly with the celebratory spirit of National...

Continue Reading
Experian Uncovers Identity Fraud Trends in 2024 Global Report

Updated Category News Views 661

Comprehensive Insights from the 2024 Global Identity & Fraud Report Experian has unveiled its 2024 Global Identity & Fraud Report, delivering an in-depth analysis of consumer and business responses to prevailing fraud patterns as well as effective mitigation strategies within the financial services sector. This extensive report is backed by data accumulated from over...

Continue Reading